Dublin, Nov. 11, 2024 (GLOBE NEWSWIRE) — The “Local Anesthesia Drugs Market Size, Share & Trends Analysis 2024-2030” report has been added to ResearchAndMarkets.com’s offering.
The global local anesthesia drugs market size is anticipated to reach USD 5.14 billion in 2030 and is projected to grow at a CAGR of 3.6% from 2024 to 2030. The rising number of surgical procedures across the globe, including cosmetic surgeries, dental procedures, and plastic surgeries, is driving the growth of local anesthetics.
There has been a considerable increase in the number of surgical procedures requiring post-operative pain relief and this trend is expected to continue throughout the forecast period. Roughly, 65% of total surgical procedures require post-operative pain management. This is likely to boost the demand for local anesthesia drugs.
The introduction of new and effective drugs such as levobupivacaine, articaine, and ropivacaine is also driving the growth of the local anesthesia drugs market across the globe. Rising healthcare expenditure in developing countries is expected to result in an increase in the number of surgeries performed in countries such as India, China, and Brazil. This is likely to contribute to market growth in the region.
Local Anesthesia Drugs Market Report Highlights
- Lidocaine dominated the market by product as of 2016 owing to its extensive use as a topical and injectable anesthetic
- By application, the market is bifurcated into injectable and surface anesthetic. The injectable segment is expected to dominate the local anesthesia drugs market during the forecast period owing to extensive usage in different surgical procedures. Advancements in drug delivery systems are expected to drive the market for surface anesthetics over the forecast period
- North America held the largest share in the market for local anesthesia drugs owing to a significant number of surgical procedures performed in the region
- Some of the key players are Aspen Pharmacare; Fresenius Kabi; Novartis, Inc.; Sagent Pharmaceutical; Pacira Pharmaceutical; Mylan; and Teva Pharmaceuticals.
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- How to sustain in these fast-evolving markets
Key Attributes
| Report Attribute | Details |
| No. of Pages | 100 |
| Forecast Period | 2023-2030 |
| Estimated Market Value (USD) in 2023 | $4.01 Billion |
| Forecasted Market Value (USD) by 2030 | $5.14 Billion |
| Compound Annual Growth Rate | 3.6% |
| Regions Covered | Global |
Key Topics Covered
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Local Anesthesia Drugs Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Local Anesthesia Drugs Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.2. PESTEL Analysis
Chapter 4. Local Anesthesia Drugs Market: Drug Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Local Anesthesia Drugs Market: Drug Movement Analysis, 2023 & 2030 (USD Million)
4.3. Bupivacaine
4.4. Ropivacaine
4.5. Lidocaine
4.6. Chloroprocaine
4.7. Prilocaine
4.8. Benzocaine
4.9. Others
Chapter 5. Local Anesthesia Drugs Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Local Anesthesia Drugs Market: Application Movement Analysis, 2023 & 2030 (USD Million)
5.3. Injectable
5.4. Surface Anesthetic
Chapter 6. Local Anesthesia Drugs Market: Regional Estimates & Trend Analysis
6.1. Local Anesthesia Drugs Share, by Region, 2023 & 2030 (USD Million)
6.2. North America
6.3. Europe
6.4. Asia Pacific
6.5. Latin America
6.6. Middle East and Africa
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
7.4.1. Johnson & Johnson Services, Inc.
7.4.2. Pfizer Inc.
7.4.3. AstraZeneca plc
7.4.4. Novartis AG.
7.4.5. Teva Pharmaceutical Industries Ltd.
7.4.6. GlaxoSmithKline plc
7.4.7. Sanofi SA
7.4.8. Merck & Co. Inc.
7.4.9. Aspen Pharmacare Holdings Limited
7.4.10. Mylan NV
For more information about this report visit https://www.researchandmarkets.com/r/ycu90g
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Local Anesthesia Drugs Market
